Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study

BACKGROUND AND OBJECTIVE: There is presently no clear evidence on the effect of combined treatment for non-cystic fibrosis (non-CF) bronchiectasis with inhaled corticosteroid (ICS) and long-acting β2-adrenergic agonist (LABA). The objective of this study is to assess the efficacy and safety of salme...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Ping, Yang, Jia-Wei, Lu, Hai-Wen, Mao, Bei, Yang, Wen-Lan, Xu, Jin-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079324/
https://www.ncbi.nlm.nih.gov/pubmed/27759640
http://dx.doi.org/10.1097/MD.0000000000005116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079324/
https://www.ncbi.nlm.nih.gov/pubmed/27759640
http://dx.doi.org/10.1097/MD.0000000000005116

Ejemplares similares